Cold medication may cause more injection site discomfort
Last reviewed: June 28, 2026 Last updated: June 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
For this reason, the first experiments of the glucose-lowering effect of GLP- 1 used continuous intravenous administration or intramuscular injections [10]
Healthcare facility capacity development in obesity management creates infrastructure for comprehensive patient care delivery
Step 3: Choose the formulation Only injectable subcutaneous formulations should be considered
Trial outcomes are useful, but they do not replace individualized care